Immuneering Corporation · NASDAQ:IMRX

Gengos Andrew bought 25,000 Immuneering Corporation shares (Form 4)

Traded Nov 13, 2026 · Filed Nov 16, 2026

On Nov 13, 2026, Gengos Andrew (Chief Financial Officer) bought 25,000 Immuneering Corporation shares at US$3.58 for US$89,500, leaving 250,000 shares. Filed Nov 16, 2026 (Form 4).

Bought
25,000 shares
Price
US$3.58
Value
US$89,500
Holding after
250,000 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 13, 2026Class A Common StockBuy25,000US$3.58250,000Direct

Source

Download original · View original at SEC

Related